Medication-based starvation of cancer cells

(Technical University of Munich (TUM)) Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide have significantly improved the therapy of hematologic malignancies such as multiple myeloma. Researchers at the Technical University of Munich (TUM) have now further decoded the mode of action in this class of medications. At the same time, they identified new innovative targeted cancer therapies.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news